| Oral 2‐hydroxyoleic acid inhibits reflex hypersensitivity and open–field‐induced anxiety after spared nerve injury G Avila‐Martin, I Galan‐Arriero, A Ferrer‐Donato, X Busquets, ... European Journal of Pain 19 (1), 111-122, 2015 | 37 | 2015 |
| Oral administration of the p38α MAPK inhibitor, UR13870, inhibits affective pain behavior after spinal cord injury I Galan-Arriero, G Avila-Martin, A Ferrer-Donato, J Gomez-Soriano, ... PAIN® 155 (10), 2188-2198, 2014 | 36 | 2014 |
| Prenatal exposure to alcohol and 3, 4-methylenedioxymethamphetamine (ecstasy) alters adult hippocampal neurogenesis and causes enduring memory deficits JJ Canales, A Ferrer-Donato Developmental neuroscience 36 (1), 10-17, 2014 | 21 | 2014 |
| Design of mesoporous silica nanoparticles for the treatment of amyotrophic lateral sclerosis (ALS) with a therapeutic cocktail based on leptin and pioglitazone D Díaz-García, Á Ferrer-Donato, JM Méndez-Arriaga, M Cabrera-Pinto, ... ACS Biomaterials Science & Engineering 8 (11), 4838-4849, 2022 | 18 | 2022 |
| Early treatment with UR13870, a novel inhibitor of p38α mitogenous activated protein kinase, prevents hyperreflexia and anxiety behaviors, in the spared nerve injury model of … I Galan-Arriero, G Avila-Martin, A Ferrer-Donato, J Gomez-Soriano, ... Neuroscience letters 604, 69-74, 2015 | 17 | 2015 |
| Alterations in leptin signaling in amyotrophic lateral sclerosis (ALS) A Ferrer-Donato, A Contreras, LM Frago, JA Chowen, ... International Journal of Molecular Sciences 22 (19), 10305, 2021 | 13 | 2021 |
| The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS) A Ferrer‐Donato, A Contreras, P Fernandez, CM Fernandez‐Martos Brain and Behavior 12 (1), e2465, 2022 | 8 | 2022 |
| Effect of ozone exposure on Amyotrophic Lateral Sclerosis (ALS) pathology using a mice model of TDP-43 proteinopathy A Rodriguez, A Ferrer-Donato, M Cabrera-Pinto, S Seseña, P Fernández, ... bioRxiv, 2021.02. 12.430915, 2021 | 4 | 2021 |
| Methodology aspects of colony maintain for a murine model of amyotrophic lateral sclerosis (ALS) TDP-43 proteinopathy C Álvaro-Alonso, Á Ferrer-Donato, E Fernández-Torres, M Carballo-Villa, ... Animals 10 (12), 2329, 2020 | 1 | 2020 |
| Effect of leptin treatment in a mouse model of TDP-43 proteinopathy A Ferrer-Donato, A Contreras, P Fernandez, CM Fernandez-Martos Preprints, 2021 | | 2021 |
